GVOKE HYPOPEN

Serial Number 88011932
Registration 6136874
700

Registration Progress

Application Filed
Jun 22, 2018
Under Examination
Jan 15, 2019
Approved for Publication
Nov 20, 2018
Published for Opposition
Nov 20, 2018
Registered
Aug 25, 2020

Trademark Image

GVOKE HYPOPEN

Basic Information

Serial Number
88011932
Registration Number
6136874
Filing Date
June 22, 2018
Registration Date
August 25, 2020
Published for Opposition
November 20, 2018
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 25, 2020
Registration
Registered
Classes
005

Rights Holder

Xeris Pharmaceuticals, Inc.

03
Address
180 N LaSalle Street, Suite 1810
Chicago, IL 60601

Ownership History

Xeris Pharmaceuticals, Inc.

Original Applicant
03
Chicago, IL

Xeris Pharmaceuticals, Inc.

Owner at Publication
03
Chicago, IL

Xeris Pharmaceuticals, Inc.

Original Registrant
03
Chicago, IL

Legal Representation

Attorney
Tracy-Gene G. Durkin

USPTO Deadlines

Next Deadline
390 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-08-25)
Due Date
August 25, 2026
Grace Period Ends
February 25, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
Jun 23, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
May 19, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Aug 25, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 24, 2020 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jul 23, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 23, 2020 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jul 23, 2020 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jul 2, 2020 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jul 2, 2020 IUAF S USE AMENDMENT FILED Loading...
May 22, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 22, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 22, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 22, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 22, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 7, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 4, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 4, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 4, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 25, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 21, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 21, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 21, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 15, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 20, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 20, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 31, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 11, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 11, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 29, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 26, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical products for the treatment of diabetes and metabolic diseases; medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for the treatment of diabetes and metabolic diseases; pre-filled syringes and vials containing pharmaceutical preparations for the treatment of diabetes and metabolic diseases
First Use Anywhere: Jun 29, 2020
First Use in Commerce: Jun 29, 2020

Classification

International Classes
005